| ORIGINAL ARTICLE |
|
| Year : 2010 | Volume
: 7
| Issue : 1 | Page : 16-19 |
|
|
Management of hypertension in thyroid disease: Results from the IMPERIAL study-1
S Kalra1, MP Baruah2, N Agrawal3, T Bandgar4, A Gandhi5, S Mitra6
1 Bharti Hospital & B.R.I.D.E, Karnal, India
2 Excel Care Hospitals, Guwahati, India
3 G.R. Medical College, Gwalior, India
4 G.S Medical College &K.E.M Hospital, Mumbai, India
5 M.M.I.M.S.R, Mullana, Ambala, India
6 USV Ltd, Mumbai, India
Correspondence Address:
S Kalra
Bharti Hospital & B.R.I.D.E, Karnal
India
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
The IMPERIAL (Indian Medical Practitioners Expressions Regarding Drug Intervention In All Aspects of MetaboLic Syndrome) study, which assessed Indian physicians' prescribing habits related to metabolic syndrome, also assessed their preferred management strategies in hypertension associated with thyroid dysfunction. This paper reviews the results related to thyroid disease, obtained from the IMPERIAL study. There is a clear consensus for the use of beta-blockers as first line antihypertensive therapy in patients with hypothyroidism. For hypothyroid patients with hypertension, ACEI, ARB and diuretics are recommended as first - line therapy by one third of the physicians each. It is hoped that these results forms the basis for a debate, and final consensus, on the management of hypertension in thyroid disorders. |
|
|
|
| [PDF]* |
|
 |
|
